JDD Buzz | Psychotherapeutic Strategies in Acne Treatment | The Expert Weighs In
Topical and systemic medications are mainstays of acne treatment, targeting excess oil, clogged pores, bacteria, and inflammation. An original article published in the June Journal of Drugs in Dermatology calls for research on an adjunct acne treatment modality that addresses an unusual target: psychological stress. The authors contend psychological stress can influence acne, and psychotherapeutic …
Topical and systemic medications are mainstays of acne treatment, targeting excess oil, clogged pores, bacteria, and inflammation. An original article published in the June Journal of Drugs in Dermatology calls for research on an adjunct acne treatment modality that addresses an unusual target: psychological stress. The authors contend psychological stress can influence acne, and psychotherapeutic … Continue reading "JDD Buzz | Psychotherapeutic Strategies in Acne Treatment | The Expert Weighs In"
From news articles to social media, “Ozempic face” is commonly used to describe facial changes that accompany rapid weight loss from GLP-1 receptor agonists. A gaunt, sunken, and aged appearance is commonly attributed to Ozempic and other GLP-1s. However, bariatric surgery and dietary changes can also lead to skin laxity and loss of facial volume. Irrespective of the weight loss method, patien … 
Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published … 
Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor.
This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to the "cosmetic elegance" of seborrhe … 
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.
An article in the March Journal …